Peddecord K M
Am J Med Technol. 1980 Jan;46(1):30-2.
Increased social pressure for accountability in the medical care fields and recognition that new and expensive health care technologies have limited impact on health status has brought acknowledgment that the United States has no rational approach to identification, evaluation, and implementation of innovative medical technologies. As in other health care sectors, comprehensive and long-range evaluation of impacts of new medical laboratory technology on both the laboratory and the patient are lacking. It is evident that as questions concerning cost effectiveness are raised, more rigorous evaluation of laboratory technologies must be undertaken. Federal legislation has mandated creation of a National Center for Health Care Technology (NCHCT) with a primary mission to stimulate assessment of health care technologies. This legislation could provide the basis for a more rational approach to technology assessment. Potential implications of technology assessment on laboratory practices and third party reimbursement policy, as well as potential opportunities for laboratory professionals, are discussed.
医疗保健领域对问责制的社会压力不断增加,以及人们认识到新的、昂贵的医疗技术对健康状况的影响有限,这使得人们承认美国在识别、评估和应用创新医疗技术方面缺乏合理的方法。与其他医疗保健领域一样,缺乏对新医学实验室技术对实验室和患者影响的全面和长期评估。显然,随着成本效益问题的提出,必须对实验室技术进行更严格的评估。联邦立法已授权设立国家医疗保健技术中心(NCHCT),其主要任务是促进对医疗保健技术的评估。这项立法可为更合理的技术评估方法提供基础。本文讨论了技术评估对实验室实践和第三方报销政策的潜在影响,以及实验室专业人员的潜在机会。